Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects

Psychopharmacology
Andrew H KempGin S Malhi

Abstract

Black box warnings for young adults under the age of 25 years indicate that antidepressants may increase risk of suicide. While underlying mechanisms for age-related treatment effects remain unclear, vagally mediated cardiovascular function may play a key role. Decreased heart rate (HR) and an increase in its variability (HRV) improve one's capacity to adapt to environmental stress and attenuate risk for suicide. Using a double blind, randomized, placebo-controlled, crossover, experimental study, we examine whether a single dose of escitalopram (20 mg) attenuates cardiovascular responses to stress under experimental conditions and determine whether age moderates these effects. Forty-four healthy females received a single dose of escitalopram (20 mg) and placebo treatment separated by a 1-week interval (>5 half-lives). HR and high frequency HRV (HF HRV normalized units; 0.15-0.40 Hz) were measured during resting state and stress. While escitalopram attenuated the increase in HR and increased HF HRV, these moderate to large effects were only significant in participants over 25 years of age. No beneficial cardiovascular effects of escitalopram were observed in those under the age of 25. Maturational differences in the development ...Continue Reading

References

Jan 1, 1986·Annals of the New York Academy of Sciences·R A Depue, M R Spoont
Dec 1, 1994·Statistical Methods in Medical Research·S Senn
Jan 14, 1998·Nature Medicine·J J Mann
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Aug 23, 2003·Journal of Psychosomatic Research·Robert PohlVikram Yeragani
Oct 3, 2003·Nature Reviews. Neuroscience·J John Mann
Jan 21, 2004·The International Journal of Neuropsychopharmacology·Andrew H Kemp, Pradeep J Nathan
Mar 17, 2004·Journal of Affective Disorders·Patricia A Straneva-MeuseSusan S Girdler
May 4, 2004·Trends in Molecular Medicine·Francine CôtéGuilan Vodjdani
Jul 14, 2005·Journal of Clinical Psychopharmacology·Arif KhanWalter A Brown
Mar 8, 2006·Archives of General Psychiatry·Tarek A HammadJudith Racoosin
May 5, 2006·Medicine and Science in Sports and Exercise·François Xavier GamelinLaurent Bosquet
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Jan 16, 2007·Pharmacology, Biochemistry, and Behavior·Fulton CrewsClyde Hodge
Mar 23, 2007·Clinical Pharmacokinetics·Niranjan Rao
Jun 16, 2007·Neuroscience and Biobehavioral Reviews·Christopher G DaveyNicholas B Allen
Feb 15, 2008·Biological Psychiatry·Albertine J OldehinkelJohan Ormel
Apr 11, 2008·Annals of the New York Academy of Sciences·B J CaseyTodd A Hare
Feb 4, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Corrado BarbuiAndrea Cipriani
Mar 17, 2009·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Zhibin LiXiaoling Wang
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Andrea CiprianiCorrado Barbui
May 2, 2009·Trials·Edward J MillsDouglas G Altman
May 9, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Julian F ThayerBjorn Helge Johnsen
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Atsuo NakagawaToshi A Furukawa
Aug 4, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Catherine J HarmerPhilip J Cowen
Sep 17, 2010·Biological Psychiatry·Carmilla M M LichtBrenda W J H Penninx
Dec 15, 2010·Clinical Psychology Review·Todd B Kashdan, Jonathan Rottenberg
Sep 8, 2011·Expert Opinion on Pharmacotherapy·Joon-Ho Ahn, Ashwin A Patkar
Oct 25, 2011·Psychosomatic Medicine·Cédric LemogneNicolas Danchin
Nov 15, 2011·Molecular Neurobiology·M Victoria Puig, Allan T Gulledge
Jul 14, 2012·European Journal of Applied Physiology·Daniel S QuintanaAndrew H Kemp

❮ Previous
Next ❯

Citations

Jan 24, 2016·Journal of Affective Disorders·Thomas ForkmannVerena Mainz
Oct 19, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Giulio ToniUNKNOWN SEEDS study group
Dec 19, 2014·The International Journal of Neuropsychopharmacology·Agorastos AgorastosCüneyt Demiralay
Dec 25, 2015·The Australian and New Zealand Journal of Psychiatry·Darryl Bassett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

© 2021 Meta ULC. All rights reserved